BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19465073)

  • 1. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo.
    El-Sayed A; Masuda T; Akita H; Harashima H
    J Pharm Sci; 2012 Feb; 101(2):879-82. PubMed ID: 22086751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y; Kogure K; Futaki S; Harashima H
    J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
    Ishitsuka T; Akita H; Harashima H
    J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
    Khalil IA; Hayashi Y; Mizuno R; Harashima H
    J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
    Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
    J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.
    Moriguchi R; Kogure K; Akita H; Futaki S; Miyagishi M; Taira K; Harashima H
    Int J Pharm; 2005 Sep; 301(1-2):277-85. PubMed ID: 16019173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
    Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
    Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles.
    Moore NM; Sheppard CL; Barbour TR; Sakiyama-Elbert SE
    J Gene Med; 2008 Oct; 10(10):1134-49. PubMed ID: 18642401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
    Mudhakir D; Akita H; Tan E; Harashima H
    J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells.
    Fujiwara T; Akita H; Harashima H
    Int J Pharm; 2010 Feb; 386(1-2):122-30. PubMed ID: 19922779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
    Kogure K
    Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation.
    Khalil IA; Futaki S; Niwa M; Baba Y; Kaji N; Kamiya H; Harashima H
    Gene Ther; 2004 Apr; 11(7):636-44. PubMed ID: 14973542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
    Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
    Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.
    Khalil IA; Kogure K; Futaki S; Harashima H
    Int J Pharm; 2008 Apr; 354(1-2):39-48. PubMed ID: 18242018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method.
    Kogure K; Moriguchi R; Sasaki K; Ueno M; Futaki S; Harashima H
    J Control Release; 2004 Aug; 98(2):317-23. PubMed ID: 15262422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2011 Jan; 149(1):58-64. PubMed ID: 20826039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.